The oncology space has seen successful adoption of biosimilars thanks to processes and formulary decisions driving conversion rates. Practices and health systems are increasingly looking at ...
COVID-19 and prevalence of venous thromboembolism among cancer patients: A nationwide inpatient sample analysis. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract ...